The 20 Best Familial Prostate Cancer Doctors Near Me in Houston, TX

Martha Mims, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Martha Mims specializes in Medical Oncology and works at BCM Medicine - Hem/Onc. To make an appointment, please call (713) 798-3750. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Mims is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Hypereosinophilic Syndrome, Essential Thrombocythemia, Non-Hodgkin Lymphoma, and Clear Cell Sarcoma. Dr. Mims is currently accepting new patients.

Dov Kadmon, M.D., is a Board-certified urologist and Professor of Urology at BCM. His practice is focused on the diagnosis and treatment of prostate cancer. He is an experienced surgeon, who has performed over 1,000 open radical prostatectomies and over 1,000 robotic-assisted (da Vinci) laparoscopic radical prostatectomies. He offers his patients state-of-the-art surgical techniques as well as an operation tailored to each individual's special needs. Dr. Kadmon has an extensive record of prostate cancer research, both basic science and clinical. He is recognized nationally and internationally for his contributions to the field and has published over 150 papers in the medical literature. He was awarded numerous grants by the National Cancer Institute to support his research and has served as a consultant to the NCI on the topic of prostate cancer. Dr. Kadmon is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Vasectomy, and Prostatectomy. Dr. Kadmon is currently accepting new patients.

Dr. Aihua Edward Yen is an oncologist specializing in genitourinary medical oncology. He is an Assistant Professor of Medicine - Hematology and Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM). He is also an Instructor of Medicine - Hematology and Oncology Section at BCM and a Urology Oncology specialist at the Bladder Cancer Center at BCM’s Dan L Duncan Comprehensive Cancer Center.Dr. Yen’s clinical interests include: prostate cancer and genitourinary cancers.Dr. Yen received his medical degree from Baylor College of Medicine, where he also completed his residency in internal medicine and a fellowship in hematology and medical oncology.Dr. Yen is board-certified in Medical Oncology by the American Board of Internal Medicine. In addition to English, Dr. Yen speaks Mandarin. Dr. Yen is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Non-Muscle Invasive Bladder Cancer. Dr. Yen is currently accepting new patients.

Erik Insko is a Radiologist practicing medicine in Houston, Texas. Dr. Insko is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Adenosine Deaminase 2 Deficiency, Prostate Cancer, Familial Prostate Cancer, and Visceromegaly. Dr. Insko is board certified in American Board Of Radiology/Diagnostic Radiology and Illinois Department Of Financial & Professional Regulation.

Louis Pisters is a Urologist practicing medicine in Houston, Texas. Dr. Pisters is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy.

John Ward is a Urologist practicing medicine in Houston, Texas. Dr. Ward is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Choriocarcinoma, and Testicular Cancer.

Henry Mok is a Radiation Oncologist practicing medicine in Houston, Texas. Dr. Mok is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer.

Mahmoud Osama is a Radiation Oncologist practicing medicine in Houston, Texas. Dr. Osama is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Anal Cancer, Prostatectomy, and Thrombectomy.

Lisly Chery is a Urologist practicing medicine in Houston, Texas. Dr. Chery is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Malakoplakia, Familial Prostate Cancer, Nephrectomy, and Prostatectomy.

Syed Yusuf is a Cardiologist practicing medicine in Houston, Texas. Dr. Yusuf is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Large-Cell Immunoblastic Lymphoma, Alveolar Soft Part Sarcoma, and Adult Soft Tissue Sarcoma.

Brian Chapin is a Urologist practicing medicine in Houston, Texas. Dr. Chapin is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

Sumit Subudhi is an Oncologist practicing medicine in Houston, Texas. Dr. Subudhi is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pseudomyxoma Peritonei, Prostatectomy, and Vertebroplasty.

Amado Zurita is an Oncologist practicing medicine in Houston, Texas. Dr. Zurita is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), and Wilms Tumor.

Brian Miles is a Urologist practicing medicine in Houston, Texas. Dr. Miles is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Vasectomy. Dr. Miles is currently accepting new patients.

Eleni Efstathiou is an Oncologist practicing medicine in Houston, Texas. Dr. Efstathiou is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Lymphofollicular Hyperplasia. Dr. Efstathiou is currently accepting new patients.

Curtis Pettaway is a Urologist practicing medicine in Houston, Texas. Dr. Pettaway is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Penile Cancer, Prostate Cancer, Familial Prostate Cancer, Penectomy, and Lymphadenectomy.

Karen Hoffman is a Radiation Oncologist practicing medicine in Houston, Texas. Dr. Hoffman is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Penile Cancer.

Richard E. Link, M.D., Ph.D., Associate Professor, is a Board-certified and fellowship-trained urologist specializing in the treatment of urologic disease affecting the kidney, ureter, and prostate. He focuses on the use of laparoscopic, robotic-assisted, percutaneous, and endoscopic techniques to treat kidney tumors, renal and ureteral obstruction, and urinary tract stones. He directs the BCM Division of Endourology and Minimally Invasive Surgery and is active, nationally, in teaching these techniques to other urologists through the American Urological Association Office of Education. He has also directed the BCM fellowship program in Minimally Invasive Urologic Surgery since 2008. Dr. Link has been an early pioneer in the development of laparoendoscopic single-site donor nephrectomy, a less invasive laparoscopic technique in which a donor kidney can be removed via only a single, small peri-umbilical incision for transplantation. He serves as Director of Living Donor Procurement for several major kidney transplant programs in Houston, including CHI/SLEH/BCM, Texas Children's Hospital, and the Houston Methodist Hospital. He also co-directs the BCM Comprehensive Stone Clinic, which provides a state-of-the-art multidisciplinary tertiary referral center for patients with complex kidney stones. Dr. Link completed his Ph.D. in Molecular and Cellular Physiology at Stanford University. His research laboratory studies the genetic basis for renal cell carcinoma and urinary tract stone disease using a combination of genetically engineered mouse models, stem cell biology, and sophisticated whole genome molecular techniques. His clinical research interests include surgical simulation, decision analysis modeling, and the application of 3D reconstruction and printing techniques to surgical education. Dr. Link is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Link is currently accepting new patients.

Guilherme Godoy, M.D., assistant professor, specializes in urologic oncology. Dr. Godoy earned his medical degree from Fundacao Universitaria do ABC in Sao Paulo, Brazil. His training includes an internship and residency in urology at Santa Casa De Sao Paulo in Vila Buarque, Brazil, and a fellowship in urologic oncology at Baylor College of Medicine. Dr. Godoy specializes in urologic oncology and management of patients with bladder cancer, kidney cancer, prostate cancer, and testis cancer. Dr. Godoy is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Ureterocele, Urothelial Cancer, Reconstructive Urology Surgery, and Nephrectomy. Dr. Godoy is currently accepting new patients.

Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Lerner is currently accepting new patients.